Search research articles
Contact Us
Filters
Showing results (101-110 of 230) with videos related to
Page
of 23
Sort By:
Toxins
|
November 10, 2011
The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity
Elisabeth Ersvaer, Astrid Olsnes Kittang, Peter Hampson, et al.
The Journal of Biological Chemistry
|
May 18, 2010
Novel antileukemic compound ingenol 3-angelate inhibits T cell apoptosis by activating protein kinase Ctheta
Wing-Yiu Lee, Peter Hampson, Lydia Coulthard, et al.
Arthritis Research & Therapy
|
October 13, 2022
Comorbidity phenotypes and risk of mortality in patients with osteoarthritis in the UK: a latent class analysis
Dawit T Zemedikun, Helena Lee, Krishnarajah Nirantharakumar, et al.
Dementia and Geriatric Cognitive Disorders
|
December 16, 2016
Acetylcholinesterase Activity Measurement and Clinical Features of Delirium
Thomas A Jackson, Hannah C Moorey, Bart Sheehan, et al.
Aging Cell
|
May 1, 2014
Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals
Jon Hazeldine, Phillipa Harris, Iain L Chapple, et al.
Exercise Immunology Review
|
August 2, 2024
Higher risk of upper respiratory tract infection post marathon running: when physical exercise becomes a threat to the immune system
Amanda Veiga Sardeli, Rafaela Bertini de Araujo, Jeffrey A Woods, et al.
BMC Medicine
|
September 22, 2023
Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care
Umer Syed, Anuradhaa Subramanian, David C Wraith, et al.
Journal of Leukocyte Biology
|
February 8, 2006
Chemokine- and adhesion-dependent survival of neutrophils after transmigration through cytokine-stimulated endothelium
Helen M McGettrick, Janet M Lord, Ke-Qing Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
November 23, 2006
T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005
Elisabeth Ersvaer, Peter Hampson, Kimberley Hatfield, et al.
Vaccine
|
May 1, 2016
Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial
Joanna E Long, Mark T Drayson, Angela E Taylor, et al.
Page
of 23
Search research articles
Search
Showing results (101-110 of 230) with videos related to
Sort By:
Page
of 23
Toxins
|
November 10, 2011
The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity
Elisabeth Ersvaer, Astrid Olsnes Kittang, Peter Hampson, et al.
The Journal of Biological Chemistry
|
May 18, 2010
Novel antileukemic compound ingenol 3-angelate inhibits T cell apoptosis by activating protein kinase Ctheta
Wing-Yiu Lee, Peter Hampson, Lydia Coulthard, et al.
Arthritis Research & Therapy
|
October 13, 2022
Comorbidity phenotypes and risk of mortality in patients with osteoarthritis in the UK: a latent class analysis
Dawit T Zemedikun, Helena Lee, Krishnarajah Nirantharakumar, et al.
Dementia and Geriatric Cognitive Disorders
|
December 16, 2016
Acetylcholinesterase Activity Measurement and Clinical Features of Delirium
Thomas A Jackson, Hannah C Moorey, Bart Sheehan, et al.
Aging Cell
|
May 1, 2014
Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals
Jon Hazeldine, Phillipa Harris, Iain L Chapple, et al.
Exercise Immunology Review
|
August 2, 2024
Higher risk of upper respiratory tract infection post marathon running: when physical exercise becomes a threat to the immune system
Amanda Veiga Sardeli, Rafaela Bertini de Araujo, Jeffrey A Woods, et al.
BMC Medicine
|
September 22, 2023
Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care
Umer Syed, Anuradhaa Subramanian, David C Wraith, et al.
Journal of Leukocyte Biology
|
February 8, 2006
Chemokine- and adhesion-dependent survival of neutrophils after transmigration through cytokine-stimulated endothelium
Helen M McGettrick, Janet M Lord, Ke-Qing Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
November 23, 2006
T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005
Elisabeth Ersvaer, Peter Hampson, Kimberley Hatfield, et al.
Vaccine
|
May 1, 2016
Morning vaccination enhances antibody response over afternoon vaccination: A cluster-randomised trial
Joanna E Long, Mark T Drayson, Angela E Taylor, et al.
Page
of 23